Endocrinology

Top Story

Report offers additional tools to determine heart disease risk, treatment in type 2 diabetes

February 6, 2016

The risk for coronary heart disease in patients with type 2 diabetes is lower than previously believed; however, proper risk assessment and strategies of care are still critical.

“By properly evaluating the level of CHD risk, physicians will know when to prescribe more aggressive and less aggressive treatment strategies for their patients,” Matthew J. Budoff, MD, an LA BioMed lead researcher and chair of The Imaging Council of the American College of Cardiology, said in a press release.

In the Journals

Top 5 online obesity stories posted in January

February 5, 2016
Endocrine Today compiled a list of the top five news reports on obesity posted in the month of January. Healio.com/Endocrinology readers were interested in…
In the Journals

BMI inaccurate marker for cardiometabolic health

February 5, 2016
Some U.S. adults are being incorrectly labeled as cardiometabolically unhealthy when using BMI category criteria, according to study findings. “Many people see…

ABIM continues to engage physicians on MOC updates

February 5, 2016
The ABIM has announced several new efforts aimed at including internists and subspecialists in the process of improving Maintenance of Certification assessments…
In the Journals

Thyroid peroxidase antibody reference levels stable across age groups

February 5, 2016
Estimated reference ranges for thyroid peroxidase antibodies in healthy euthyroid adults are different for men and women but do not vary by age for either sex, according…
More News Headlines »
CME

Managing Obesity in 2015: Setting the Framework and Assessing All of the Options

This activity is supported by an educational grant from Novo Nordisk.

This CME activity is based on the slides and lectures presented by the faculty at the symposium, Managing Obesity in…
More »
Meeting News CoverageVideo

VIDEO: Exercise, clinician support necessary for patients with fatty liver

November 14, 2015
More »
Featured
CME

Real-world Use of Anti-VEGF Therapy

This activity is supported by an educational grant from Genentech, Inc.

Anti-VEGF is well established as first-line therapy for the treatment of diabetic macular edema (DME) and age-related…
More »
Current Issues
View the Current Issues